Inhibition of v-Mos Kinase Activity by Protein Kinase A

REFERENCES

• Adra, C. N., P. H. Boer, and M. W. McBurney. 1987. Cloning and expression of the mouse pgk-1 gene and the nucleotide sequence of its promoter. Gene 60:65–74.
   PubMed Web of Science ®Google Scholar
• Al-Bagdadi, F., B. Singh, and R. B. Arlinghaus. 1990. Evidence for involvement of the protein kinase C pathway in the activation of p37v-mos protein kinase. Oncogene 5:1251–1257.
   PubMedGoogle Scholar
• Arlinghaus, R. B. 1985. The ts110 Moloney mouse sarcoma virus system: gag-mos gene products and cellular transformation. J. Gen. Virol. 66:1845–1853.
   PubMedGoogle Scholar
• Armstrong, R., W. Wen, J. Meinkoth, S. Taylor, and M. Montminy. 1995. A refractory phase in cyclic AMP-responsive transcription requires down regulation of protein kinase A. Mol. Cell. Biol. 15:1826–1832.
   PubMedGoogle Scholar
• Bai, W., R. B. Arlinghaus, and B. Singh. Unpublished data.
   Google Scholar
• Bai, W., B. Singh, W. L. Karshin, R. A. Shonk, and R. B. Arlinghaus. 1991. Phosphorylation of v-Mos Ser-47 by the mitotic form of p34cdc2. Oncogene 6:1715–1723.
   PubMedGoogle Scholar
• Bai, W., B. Singh, Y. Yang, L. S. Ramagli, M. Nash, N. K. Herzog, and R. B. Arlinghaus. 1992. The physical interaction between p37env-mos and tubulin structures. Oncogene 7:493–500.
   PubMedGoogle Scholar
• Bornslaeger, E. A., P. Mattei, and R. M. Schultz. 1986. Involvement of cAMP-dependent protein kinase and protein phosphorylation in regulation of mouse oocyte maturation. Dev. Biol. 114:453–462.
   PubMed Web of Science ®Google Scholar
• Boyle, W. J., P. van der Geer, and T. Hunter. 1991. Phosphopeptide mapping and phosphoamino acid analysis by two-dimensional separation on thin-layer cellulose plates. Methods Enzymol. 201:110–149.
   PubMed Web of Science ®Google Scholar
• Burgering, B. M., G. J. Pronk, P. C. vanWeeren, P. Chardin, and J. L. Bos. 1993. cAMP antagonizes p21ras-directed activation of extracellular signal-regulated kinase 2 and phosphorylation of mSos nucleotide exchange factor. EMBO J. 12:4211–4220.
   PubMedGoogle Scholar
• Chackalaparampil, I., and D. Shalloway. 1988. Altered phosphorylation and activation of pp60c-src during fibroblast mitosis. Cell 52:801–810.
   PubMed Web of Science ®Google Scholar
• Chen, M., and J. C. Cooper. 1995. Ser-3 is important for regulating Mos interaction with and stimulation of mitogen-activated protein kinase kinase. Mol. Cell. Biol. 15:4727–4734.
   PubMed Web of Science ®Google Scholar
• Coghlan, V. M., B. A. Perrino, M. Howard, L. K. Langeberg, J. B. Hicks, W. M. Gallatin, and J. D. Scott. 1995. Association of protein kinase A and protein phosphatase 2B with a common anchoring protein. Science 267:108–111.
   PubMed Web of Science ®Google Scholar
• Colledge, W. W., M. B. L. Carlton, G. B. Udy, and M. J. Evans. 1994. Disruption of c-mos causes parthenogenetic development of unfertilized mouse eggs. Nature (London) 370:65–68.
   PubMed Web of Science ®Google Scholar
• Crews, C. M., A. A. Alessandrini, and R. L. Erikson. 1991. Mouse Erk-1 gene product is a serine/threonine protein kinase that has the potential to phosphorylate tyrosine. Proc. Natl. Acad. Sci. USA 88:8845–8849.
   PubMedGoogle Scholar
• Daar, I., N. Yew, and G. F. Vande Woude. 1993. Inhibition of mos-induced oocyte maturation by protein kinase A. J. Cell Biol. 120:1197–1202.
   PubMed Web of Science ®Google Scholar
• Freeman, R. S., and D. J. Donoghue. 1989. Transforming mutant v-mos protein kinases that are deficient in in vitro autophosphorylation. Mol. Cell. Biol. 9:4087–4090.
   PubMedGoogle Scholar
• Freeman, R. S., J. P. Kanki, S. M. Ballantyne, K. M. Pickham, and D. J. Donoghue. 1990. Effects of the v-mos oncogene on Xenopus development: meiotic induction in oocytes and mitotic arrest in cleaving embryos. J. Cell Biol. 111:533–541.
   PubMedGoogle Scholar
• Freeman, R. S., A. N. Meyer, J. Li, and D. J. Donoghue. 1992. Phosphorylation of conserved serine residues does not regulate the ability of mosxe protein kinase to induce oocyte maturation or function as cytostatic factor. J. Cell Biol. 116:725–735.
   PubMed Web of Science ®Google Scholar
• Gallick, G. E., J. T. Sparrow, B. Singh, S. A. Maxwell, L. H. Stanker, and R. B. Arlinghaus. 1985. Recognition of mos-related proteins with an antiserum to a peptide of the v-mos gene product. J. Gen. Virol. 66:945–955.
   PubMedGoogle Scholar
• Ghosh, A., and M. E. Greenberg. 1995. Calcium signaling in neurons: molecular mechanisms and cellular consequences. Science 268:239–247.
   PubMed Web of Science ®Google Scholar
• Hafner, S., H. S. Adler, H. Mischak, P. Janosch, G. Heidecker, A. Wolfman, S. Pippig, M. Lohse, M. Ueffing, and W. Kolch. 1994. Mechanism of inhibition of Raf-1 by protein kinase A. Mol. Cell. Biol. 14:6696–6703.
   PubMedGoogle Scholar
• Hanks, S. K., A. M. Quinn, and T. Hunter. 1988. The protein kinase family: conserved features and deduced phylogeny of the catalytic domains. Science 241:42–52.
   PubMed Web of Science ®Google Scholar
• Hashimoto, N., and T. Kishimoto. 1988. Regulation of meiotic metaphase by a cytoplasmic maturation-promoting factor during mouse oocyte maturation. Dev. Biol. 126:242–252.
   PubMed Web of Science ®Google Scholar
• Hashimoto, N., N. Watanabe, Y. Furuta, H. Tamemoto, N. Sagata, M. Yokoyama, K. Okazaki, M. Nagayoshi, N. Takeda, Y. Ikawa, and S. Aizawa. 1994. Parthenogenetic activation of oocytes in c-mos-deficient mice. Nature (London) 370:68–71.
   PubMed Web of Science ®Google Scholar
• Herzog, N. K., M. Nash, L. S. Ramagli, and R. B. Arlinghaus. 1990. v-mos protein produced by in vitro translation has protein kinase activity. J. Virol. 64:3093–3096.
   PubMedGoogle Scholar
• Hunter, T. 1995. Protein kinases and phosphatases: the yin and yang of protein phosphorylation and signaling. Cell 80:225–236.
   PubMed Web of Science ®Google Scholar
• Liu, J., B. Singh, D. Wlodek, and R. B. Arlinghaus. 1990. Cell cycle dependent structural and functional alteration of P85gag-mos protein kinase activity. Oncogene 5:171–178.
   PubMed Web of Science ®Google Scholar
• Maller, J. 1983. Interaction of steroids with the cyclic nucleotide system in amphibian oocytes. Adv. Cyclic Nucleotide Res. 15:295–236.
   Google Scholar
• Mansour, S. J., W. T. Matten, A. S. Hermann, J. M. Candia, S. Rong, K. Fukasawa, G. F. Vande Woude, and N. G. Ahn. 1994. Transformation of mammalian cells by constitutively active MAP kinase kinase. Science 265:966–970.
   PubMed Web of Science ®Google Scholar
• Matten, W., I. Daar, and G. F. Vande Woude. 1994. Protein kinase A acts at multiple points to inhibit Xenopus oocyte maturation. Mol. Cell. Biol. 14:4419–4426.
   PubMed Web of Science ®Google Scholar
• Maxwell, S. A., and R. B. Arlinghaus. 1985. Serine kinase activity associated with Moloney murine sarcoma virus 124-encoded p37mos. Virology 143:321–333.
   PubMed Web of Science ®Google Scholar
• Mellon, P. L., C. H. Clegg, L. A. Correll, and G. S. McKnight. 1989. Regulation of transcription by cyclic AMP-dependent protein kinase. Proc. Natl. Acad. Sci. USA 86:4887–4891.
   PubMed Web of Science ®Google Scholar
• Mochly-Rosen, D. 1995. Localization of protein kinases by anchoring proteins: a theme in signal transduction. Science 268:247–251.
   PubMed Web of Science ®Google Scholar
• Monfar, M., K. P. Lemon, T. C. Grammer, L. Cheatham, J. Chung, C. J. Vlahos, and J. Blenis. 1995. Activation of pp70/85 S6 kinases in interleukin-2-responsive lymphoid cells is mediated by phosphatidylinositol 3-kinase and inhibited by cyclic AMP. Mol. Cell. Biol. 15:326–337.
   PubMedGoogle Scholar
• Nebreda, A. R. and T. Hunt. 1993. The c-mos proto-oncogene protein kinase turns on and maintains the activity of MAP kinase, but not MPF, in cell-free extracts of Xenopus oocytes and eggs. EMBO J. 12:1979–1986.
   PubMed Web of Science ®Google Scholar
• Nishizawa, M., K. Okazaki, N. Furuno, N. Watanabe, and N. Sagata. 1992. The “second-codon rule” and autophosphorylation govern the stability and activity of Mos during the meiotic cell cycle in Xenopus oocytes. EMBO J. 11:2433–2446.
   PubMed Web of Science ®Google Scholar
• Okazaki, K., and N. Sagata. 1995. MAP kinase activation is essential for oncogenic transformation of NIH 3T3 cells by Mos. Oncogene 10:1149–1157.
   PubMedGoogle Scholar
• O’Keefe, S. J., H. Wolfes, A. A. Kiessling, and G. M. Cooper. 1989. Microinjection of antisense c-mos oligonucleotides prevents meiosis II in the maturing mouse egg. Proc. Natl. Acad. Sci. USA 86:7038–7042.
   PubMedGoogle Scholar
• Papkoff, J., I. M. Verma, and T. Hunter. 1982. Detection of a transforming gene product in cells transformed by Moloney murine sarcoma virus. Cell 29:417–426.
   PubMedGoogle Scholar
• Paules, R. S., R. Buccione, R. C. Moschel, G. F. Vande Woude, and J. J. Eppig. 1989. Mouse mos proto-oncogene product is present and functions during oogenesis. Proc. Natl. Acad. Sci. USA 86:5395–5399.
   PubMedGoogle Scholar
• Pham, C. D., R. B. Arlinghaus, C.-F. Zheng, K.-L. Guan, and B. Singh. 1995. Characterization of MEK1 phosphorylation by the v-Mos protein. Oncogene 10:1683–1688.
   PubMedGoogle Scholar
• Posada, J., N. Yew, N. G. Ahn, G. F. Vande Woude, and J. A. Cooper. 1993. Mos stimulates MAP kinase in Xenopus oocytes and activates a MAP kinase kinase in vitro. Mol. Cell. Biol. 13:2546–2553.
   PubMed Web of Science ®Google Scholar
• Resing, K., S. J. Mansour, A. S. Hermann, R. S. Johnson, J. M. Candia, K. Fukasawa, G. F. Vande Woude, and N. G. Ahn. 1995. Determination of v-Mos-catalyzed phosphorylation sites and autophosphorylation sites on MAP kinase kinase by ESI/MS. Biochemistry 34:2610–2620.
   PubMedGoogle Scholar
• Sagata, N., M. Oskarsson, T. Copeland, J. Brumbaugh, and G. F. Vande Woude. 1988. Function of c-mos proto-oncogene product in meiotic maturation in Xenopus oocytes. Nature (London) 335:519–525.
   PubMed Web of Science ®Google Scholar
• Sagata, N., N. Watanabe, G. F. Vande Woude, and Y. Ikawa. 1989. The c-mos proto-oncogene product is a cytostatic factor responsible for meiotic arrest in vertebrate eggs. Nature (London) 342:512–518.
   PubMed Web of Science ®Google Scholar
• Schorderet-Slatkine, S., M. Schorderet, and E. E. Baulieu. 1982. Cyclic AMP-mediated control of meiosis: effects of progesterone, cholera toxin, and membrane-active drugs in Xenopus laevis oocytes. Proc. Natl. Acad. Sci. USA 79:850–854.
   PubMed Web of Science ®Google Scholar
• Schultz, R. M., R. R. Montgomery, and J. R. Belanoff. 1983. Regulation of mouse oocyte meiotic maturation: implication of a decrease in oocyte cAMP and protein dephosphorylation in commitment to resume meiosis. Dev. Biol. 97:264–273.
   PubMed Web of Science ®Google Scholar
• Seth, A., and G. F. Vande Woude. 1985. Nucleotide sequence and biochemical activity of the Moloney murine sarcoma virus strain HT-1 mos gene. J. Virol. 56:144–152.
   PubMed Web of Science ®Google Scholar
• Shibuya, E. K., and J. V. Ruderman. 1993. Mos induces the in vitro activation of mitogen-activated protein kinases in lysates of frog oocytes and mammalian somatic cells. Mol. Biol. Cell 4:781–790.
   PubMedGoogle Scholar
• Singh, B. Unpublished data.
   Google Scholar
• Singh, B., F. Al-Bagdadi, J. Liu, and R. B. Arlinghaus. 1990. Use of antipeptide antibodies to probe the catalytic activity of p37v-mos. Virology 178:535–542.
   PubMedGoogle Scholar
• Singh, B., and R. B. Arlinghaus. 1989. Vimentin phosphorylation by p37mos protein kinase in vitro and generation of 50 kDa cleavage product in v-mos transformed cells. Virology 173:144–156.
   PubMedGoogle Scholar
• Singh, B., and R. B. Arlinghaus. 1992. The mos proto-oncogene product: its role in oocyte maturation, metaphase arrest and neoplastic transformation. Mol. Carcinog. 6:182–189.
   PubMed Web of Science ®Google Scholar
• Singh, B., M. Hannink, D. J. Donoghue, and R. B. Arlinghaus. 1986. p37mos associated serine/threonine protein kinase activity correlates with the cellular transformation function of v-mos. J. Virol. 60:1148–1152.
   PubMedGoogle Scholar
• Singh, B., N. K. Herzog, J. Liu, and R. B. Arlinghaus. 1988. p37mos encoded by the HT-1 strain of Moloney murine sarcoma virus has an associated protein kinase activity. Oncogene 3:79–85.
   Google Scholar
• Singh, B., C. Stocking, R. Walker, Y. Yang, W. Ostertag, and R. B. Arlinghaus. 1992. v-Mos proteins encoded by myeloproliferative sarcoma virus and its ts159 mutant. J. Virol. 66:1267–1272.
   PubMedGoogle Scholar
• Singh, B., C. Wittenberg, M. Hannink, S. I. Reed, D. J. Donoghue, and R. B. Arlinghaus. 1988. The histidine-221 to tyrosine substitution in v-Mos abolishes its biological function and its protein kinase activity. Virology 164:114–120.
   PubMedGoogle Scholar
• Songyang, Z., S. Blechner, N. Hoagland, M. F. Hoekstra, H. Piwnica-Worms, and L. C. Cantley. 1994. Use of an oriented peptide library to determine the optimal substrates of protein kinases. Curr. Biol. 4:973–982.
   PubMed Web of Science ®Google Scholar
• Urner, R., W. L. Hermann, E. E. Balieu, and S. Schorderet-Slatkine. 1983. Inhibition of denuded mouse oocyte meiotic maturation by forskolin, an activator of adenylate cyclase. Endocrinology 113:1170–1172.
   PubMedGoogle Scholar
• van Beveren, C., F. van Straaten, J. A. Galleshaw, and I. M. Verma. 1981. Nucleotide sequence of the genome of a murine sarcoma virus. Cell 27:97–108.
   PubMed Web of Science ®Google Scholar
• Yang, Y., R. B. Arlinghaus, and B. Singh. Unpublished data.
   Google Scholar
• Zhao, X., B. Batten, B. Singh, and R. B. Arlinghaus. 1990. Requirement of the c-mos protein kinase for murine meiotic maturation. Oncogene 5:1727–1730.
   PubMed Web of Science ®Google Scholar
• Zhao, X., B. Singh, and R. B. Arlinghaus. 1991. Inhibition of c-mos protein kinase blocks mouse zygotes at the pronuclei stage. Oncogene 6:1423–1426.
   PubMedGoogle Scholar
• Zhou, R., M. Oskarsson, R. S. Paules, N. Schulz, D. Cleveland, and G. F. Vande Woude. 1991. Ability of the c-mos product to associate with and phosphorylate tubulin. Science 251:671–675.
   PubMed Web of Science ®Google Scholar